1364 (Emtricitabine and Tenofovir Disoproxil Fumarate 100 mg / 150 mg)
Pill with imprint 1364 is White, Elliptical/Oval and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 100 mg / 150 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 100 mg / 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1364
Emtricitabine and Tenofovir Disoproxil Fumarate
- Imprint
- 1364
- Strength
- 100 mg / 150 mg
- Color
- White
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70710-1364
Related images for "1364"
More about emtricitabine / tenofovir
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (36)
- Drug images
- Drug class: antiviral combinations
Patient resources
- Drug Information
- Emtricitabine and tenofovir (Advanced Reading)
- Emtricitabine and Tenofovir Disoproxil Fumarate
Other brands
Truvada, AccessPak for HIV PEP Basic
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.